The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-((4-Chlorobenzyl)amino)-2-oxoethoxy)-N-phenylbenzamide ID: ALA4875589
PubChem CID: 164626147
Max Phase: Preclinical
Molecular Formula: C22H19ClN2O3
Molecular Weight: 394.86
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COc1ccc(C(=O)Nc2ccccc2)cc1)NCc1ccc(Cl)cc1
Standard InChI: InChI=1S/C22H19ClN2O3/c23-18-10-6-16(7-11-18)14-24-21(26)15-28-20-12-8-17(9-13-20)22(27)25-19-4-2-1-3-5-19/h1-13H,14-15H2,(H,24,26)(H,25,27)
Standard InChI Key: UQJFSZSFPMJBPU-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
16.9750 -22.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6847 -22.1403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6847 -21.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9732 -20.9124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2682 -21.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2682 -22.1408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5607 -20.9107 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.3930 -22.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1001 -22.1381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8084 -22.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5155 -22.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2239 -22.5433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9309 -22.1336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6364 -22.5413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3422 -22.1323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3422 -21.3142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6289 -20.9069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9309 -21.3183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0487 -20.9036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0487 -20.0864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7576 -21.3101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4641 -20.8995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1701 -21.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8762 -20.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8762 -20.0785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1604 -19.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4641 -20.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8084 -23.3627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
6 5 2 0
6 1 1 0
5 7 1 0
2 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
10 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.86Molecular Weight (Monoisotopic): 394.1084AlogP: 4.29#Rotatable Bonds: 7Polar Surface Area: 67.43Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.12CX Basic pKa: ┄CX LogP: 4.13CX LogD: 4.13Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.63Np Likeness Score: -1.67
References 1. Turgutalp B, Uslu M, Helvacioglu S, Charehsaz M, Gurdal EE, Sippl W, Kocabas F, Yarim M.. (2021) Lead Optimization and Structure-Activity Relationship Studies on Myeloid Ecotropic Viral Integration Site 1 Inhibitor., 64 (19.0): [PMID:34542289 ] [10.1021/acs.jmedchem.1c00972 ]